The design, make, test, and analyze cycle (DMTA), which drives early-stage drug discovery, requires workflows and automated methods for sample storage and tracking, low volume dispensing of ...

Automated sample-management systems firm Nexus Biosystems is to acquire Tecan’s Switzerland-based sample-management business Remp and related assets. The companies say that they will also ...